BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
IDT Corp
IDT
$1.65B
| $22.6K | ﹤0.01% |
3,433
+2,605
| +315% | +$17.1K |
|
3027
Galectin Therapeutics
GALT
$381M
| $22.5K | ﹤0.01% |
8,429
+7,171
| +570% | +$19.1K |
|
3028
Gencor Industries
GENC
$228M
| $22.5K | ﹤0.01% |
2,039
+1,661
| +439% | +$18.3K |
|
3029
Concrete Pumping Holdings
BBCP
$368M
| $22.5K | ﹤0.01% |
6,293
+4,930
| +362% | +$17.6K |
|
|
EARN
3030
Ellington Residential Mortgage REIT
EARN
$212M
| $22.4K | ﹤0.01% |
2,022
+1,681
| +493% | +$18.7K |
|
|
PCTI
3031
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $22.4K | ﹤0.01% |
3,954
+3,294
| +499% | +$18.6K |
|
3032
Bankwell Financial Group
BWFG
$352M
| $22.4K | ﹤0.01% |
1,581
+1,341
| +559% | +$19K |
|
|
NYMX
3033
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $22.3K | ﹤0.01% |
9,081
+7,592
| +510% | +$18.7K |
|
3034
Franklin Financial Services
FRAF
$213M
| $22.2K | ﹤0.01% |
1,036
+818
| +375% | +$17.5K |
|
|
AAIC
3035
DELISTED
Arlington Asset Investment Corp.
AAIC
| $22.1K | ﹤0.01% |
7,787
+5,853
| +303% | +$16.6K |
|
3036
United Security Bancshares
UBFO
$167M
| $22.1K | ﹤0.01% |
3,615
+2,454
| +211% | +$15K |
|
3037
Esquire Financial Holdings
ESQ
$833M
| $22.1K | ﹤0.01% |
1,472
+1,099
| +295% | +$16.5K |
|
3038
KB Financial Group
KB
$30.6B
| $22K | ﹤0.01% |
685
-19
| -3% | -$610 |
|
3039
Westwood Holdings Group
WHG
$163M
| $21.9K | ﹤0.01% |
1,969
+1,504
| +323% | +$16.8K |
|
3040
Cidara Therapeutics
CDTX
$1.64B
| $21.9K | ﹤0.01% |
384
+321
| +510% | +$18.3K |
|
|
MR
3041
DELISTED
Montage Resources Corporation Common Stock
MR
| $21.9K | ﹤0.01% |
4,986
+3,837
| +334% | +$16.8K |
|
3042
First Bank
FRBA
$421M
| $21.9K | ﹤0.01% |
3,525
+2,937
| +499% | +$18.2K |
|
|
MFNC
3043
DELISTED
Mackinac Financial Corporation
MFNC
| $21.8K | ﹤0.01% |
2,261
+1,805
| +396% | +$17.4K |
|
3044
Genprex
GNPX
$8.65M
| $21.6K | ﹤0.01% |
161
+134
| +496% | +$18K |
|
|
ALSK
3045
DELISTED
Alaska Communications Systems
ALSK
| $21.6K | ﹤0.01% |
10,818
+8,874
| +456% | +$17.7K |
|
|
AGS
3046
DELISTED
PlayAGS
AGS
| $21.6K | ﹤0.01% |
6,108
+4,662
| +322% | +$16.5K |
|
3047
BankFinancial
BFIN
$154M
| $21.6K | ﹤0.01% |
2,993
+2,404
| +408% | +$17.4K |
|
|
CLPR
3048
Clipper Realty
CLPR
$70.6M
| $21.6K | ﹤0.01% |
3,571
+2,392
| +203% | +$14.5K |
|
|
PFSW
3049
DELISTED
PFSweb, Inc.
PFSW
| $21.6K | ﹤0.01% |
3,222
+2,698
| +515% | +$18K |
|
|
IMDX
3050
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$91M
| $21.5K | ﹤0.01% |
774
+641
| +482% | +$17.8K |
|